j cyst fibres lsuppl nissim a, gofur y, vessillier s, adams g and diclofenac pot chernajovsky y methods for targeting biologicals to specific disease sites trends mol med conway sp, brownlee kg, denton m and peckham dg antibiotic treatment of multidrugresistant flexeril drug organisms in cystic fibrosis am j respir med patel hm serum opsonins and liposomes their flexeril drug interaction and opsonophagocytosis crit rev ther drug can syst l szebeni j the interaction of liposomes with trileptal oxcarbazepine anticonvulsants the complement system crit rev ther flexeril drug drug carrier syst l bradley aj and devine dv the complement system in liposome clearance can complement deposition be inhibited?